tiprankstipranks
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market
HOWL
Werewolf Therapeutics
RESEARCH TOOLSreports

Werewolf Therapeutics (HOWL) Financial Statements

789 Followers

Werewolf Therapeutics Financial Overview

Werewolf Therapeutics's market cap is currently $43.66M. The company's EPS TTM is $-0.2; its P/E ratio is -0.48; Werewolf Therapeutics is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 1.89M$ 19.94M$ 16.40M$ 0.00
Gross Profit$ -1.63M$ 71.00K$ 18.18M$ 13.89M$ 0.00
Operating Income$ -60.68M$ -73.59M$ -40.50M$ -56.06M$ -50.09M
EBITDA$ -59.04M$ -64.05M$ -32.47M$ -51.30M$ -49.87M
Net Income$ -60.82M$ -70.52M$ -37.37M$ -53.81M$ -49.98M
Balance Sheet
Cash & Short-Term Investments$ 57.95M$ 111.00M$ 134.34M$ 129.31M$ 157.53M
Total Assets$ 69.40M$ 126.93M$ 174.83M$ 160.25M$ 179.25M
Total Debt$ 9.44M$ 37.09M$ 51.92M$ 14.68M$ 15.66M
Net Debt$ -48.52M$ -73.91M$ -82.42M$ -114.63M$ -141.87M
Total Liabilities$ 44.59M$ 53.54M$ 63.46M$ 37.91M$ 26.46M
Stockholders' Equity$ 24.80M$ 73.39M$ 111.37M$ 122.34M$ 152.79M
Cash Flow
Free Cash Flow$ -60.29M$ -56.44M$ -33.38M$ -44.21M$ -43.37M
Operating Cash Flow$ -60.29M$ -56.19M$ -32.61M$ -40.60M$ -42.88M
Investing Cash Flow$ 0.00$ -254.00K$ -769.00K$ -3.61M$ -498.00K
Financing Cash Flow$ 6.03M$ 13.08M$ 58.43M$ 15.91M$ 109.43M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History

Income Statement >

Werewolf Therapeutics Debt to Assets

Balance Sheet >

Werewolf Therapeutics Cash Flow

Cash Flow >

Werewolf Therapeutics Forecast EPS vs Actual EPS

Earnings >